New MAOI transdermal patch available to treat major depressive disorder in adults
FDA advisory committee recommends black box warning for ADHD drugs
Valproic acid and lopinavir/ritonavir
Predictors of behavioral disinhibition in teen depression
Response to atomoxetine across the life span
News Notes
Venlafaxine and the rapid development of anasarca
From the FDA